Caricamento...
A phase 2 trial of N-Acetylcysteine in Biliary atresia after Kasai portoenterostomy
BACKGROUND: Biliary atresia (BA) is a life-threatening liver disease of infancy, characterized by extrahepatic biliary obstruction, bile retention, and progressive liver injury. The Kasai portoenterostomy (KP) is BA's only nontransplant treatment. Its success is variable and depends on restorat...
Salvato in:
| Pubblicato in: | Contemp Clin Trials Commun |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6542754/ https://ncbi.nlm.nih.gov/pubmed/31193715 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.conctc.2019.100370 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|